Tanner Pharma Expands Global Access to Botensilimab and Balstilimab Through Partnership With Agenus

Contributed by: Business Wire

Logo

Tags

Research

Genetics

Clinical Trials

Biotechnology

Health

Pharmaceutical

Other Science

Science

Oncology

Agenus

More Like This

Agenus and Zydus Lifesciences Enter $141M Strategic Collaboration to Advance BOT/BAL, Expand Zydus’ Biologics Manufacturing in the US

Tiziana Life Sciences Announces Foralumab Dosing of Four New Patients in the Expanded Access Program for Multiple Sclerosis

BerGenBio Announces First Patient Entered Into Advanced Adenocarcinoma Lung Cancer Trial

Merus Announces Financial Results for the Fourth Quarter and Full Year 2024 and Provides Business Update

Merus Announces FDA Approval of BIZENGRI® (zenocutuzumab-zbco) for NRG1+ Pancreatic Adenocarcinoma and NRG1+ Non–Small Cell Lung Cancer (NSCLC) Based on Safety and Efficacy Data From the eNRGy Study

BerGenBio Announces NCI Clinical Collaboration with UT Health San Antonio and Sobi®

GlobeNewswire associated0

Essential Pharma reaches agreement with AGC Biologics for late phase clinical manufacturing of its immunotherapy candidate for the treatment of high-risk neuroblastoma

PR Newswire associated0

Medison Pharma Announces Agreement with Regeneron Pharmaceuticals to Commercialize Libtayo® (cemiplimab) in Multiple Countries